DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chen WC, Chang YS, Hsu HP. et al.
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
Oncotarget 2015;
6 (40) 42923-42937
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.